These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1479521)

  • 1. Raised plasma hypoxanthine levels as a prognostic sign in preterm babies with respiratory distress syndrome treated with natural surfactant.
    Saugstad OD; Tubman TR; Gloppestad K; Halliday HL; Oyasaeter S; Curstedt T; Robertson B
    J Perinat Med; 1992; 20(5):379-85. PubMed ID: 1479521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral blood flow and plasma hypoxanthine in relation to surfactant treatment.
    Bell AH; Skov L; Lundstrøm KE; Saugstad OD; Greisen G
    Acta Paediatr; 1994 Sep; 83(9):910-4. PubMed ID: 7819684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma hypoxanthine and xanthine levels in the early newborn period in problem-free preterm babies and those with idiopathic respiratory distress syndrome.
    Karmazsin L; Balla G
    Acta Paediatr Hung; 1985; 26(1):1-9. PubMed ID: 3986048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High postmortem levels of hypoxanthine in the vitreous humor of premature babies with respiratory distress syndrome.
    Saugstad OD; Rognum TO
    Pediatrics; 1988 Mar; 81(3):395-8. PubMed ID: 3422735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized multicentre trial of treatment with porcine natural surfactant for moderately severe neonatal respiratory distress syndrome. The Collaborative European Multicentre Study Group.
    Bevilacqua G; Halliday H; Parmigiani S; Robertson B
    J Perinat Med; 1993; 21(5):329-40. PubMed ID: 8126628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the plasma kallikrein-kinin system in respiratory distress syndrome.
    Saugstad OD; Buø L; Johansen HT; Røise O; Aasen AO
    Pediatr Res; 1992 Oct; 32(4):431-5. PubMed ID: 1437396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
    Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased ADMA levels are associated with poor pulmonary outcome in preterm neonates.
    Kavurt S; Demirel N; Bas AY; Ulubas Isık D; Ozcan B; Aydemir O
    J Matern Fetal Neonatal Med; 2017 Apr; 30(7):864-869. PubMed ID: 27268203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of treating neonates with surfactants for respiratory distress syndrome. I. Importance of gas exchange].
    Gadzinowski J; Szymankiewicz M; Twarowska I; Halliday H
    Ginekol Pol; 1992; 63(3):101-4. PubMed ID: 1303908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of preterm neonates with severe respiratory distress syndrome using exogenous natural surfactants of porcine origin].
    Valls i Soler A; López de Heredia I; Hernaéz Ortega E; Román Echevarría L; Gastiasoro Cuesta E; Robertson B
    An Esp Pediatr; 1992 May; 36(5):375-81. PubMed ID: 1616198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant treatment and incidence of intraventricular haemorrhage in severe respiratory distress syndrome.
    McCord FB; Curstedt T; Halliday HL; McClure G; Reid MM; Robertson B
    Arch Dis Child; 1988 Jan; 63(1):10-6. PubMed ID: 3279916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant replacement therapy in premature babies with respiratory distress syndrome: factors affecting the response to surfactant and comparison of outcome from 1982-86 and 1987-91.
    Konishi M; Chida S; Shimada S; Kasai T; Murakami Y; Cho K; Fujii Y; Maeta H; Fujiwara T
    Acta Paediatr Jpn; 1992 Dec; 34(6):617-30. PubMed ID: 1285509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome. Collaborative European Multicentre Study Group.
    Robertson B; Curstedt T; Tubman R; Strayer D; Berggren P; Kok J; Koppe J; van Sonderen L; Halliday H; McClure G
    Eur J Pediatr; 1992 May; 151(5):372-6. PubMed ID: 1396894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: implications for nursing care.
    Sittlington N; Tubman R; Halliday HL
    Midwifery; 1991 Mar; 7(1):20-4. PubMed ID: 2011088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.
    Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentration of elastase-alpha 1-proteinase inhibitor complex in surfactant-treated preterm neonates with respiratory distress syndrome.
    Tegtmeyer FK; Möller J; Richter A; Wilken B; Fischer T
    Eur Respir J; 1994 Feb; 7(2):260-4. PubMed ID: 8162977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surfactant treatment of premature infants with respiratory distress syndrome].
    Saugstad OD; Gloppestad K
    Tidsskr Nor Laegeforen; 1990 Nov; 110(29):3737-41. PubMed ID: 2274941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxanthine as a measurement of hypoxia.
    Saugstad OD
    Pediatr Res; 1975 Apr; 9(4):158-61. PubMed ID: 1143950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary pathology in surfactant-treated preterm infants with respiratory distress syndrome: an autopsy study.
    Toti P; Buonocore G; Rinaldi G; Catella AM; Bracci R
    Biol Neonate; 1996; 70(1):21-8. PubMed ID: 8853843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the clinical response to surfactant replacement therapy in babies with severe respiratory distress syndrome. Collaborative European Multicentre Study Group.
    Eur J Pediatr; 1991 Apr; 150(6):433-9. PubMed ID: 2040354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.